Analytical Data
-
Gene name
TP_0608
- Application
-
Alternative Names
TP_0608; Uncharacterized protein TP_0608
-
Species
Treponema pallidum
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O83617
-
Expression Region
77-296aa
-
Molecular Weight
30.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TP_0608 is a recombinant protein that has gained attention in the field of biotechnology and molecular biology due to its potential applications in therapeutic and diagnostic research. This protein is derived from a pathogenic organism, highlighting its relevance in understanding disease mechanisms and developing targeted treatments. The study of TP_0608 allows researchers to explore its structural and functional properties, which may reveal insights into its role in pathogen-host interactions. Additionally, the recombinant production of TP_0608 facilitates the examination of its immunogenicity and biochemical characteristics, making it a valuable candidate for vaccine development or as a biomarker for disease detection. Investigating this protein contributes to a broader understanding of infectious diseases and could lead to innovative strategies for prevention and treatment, emphasizing the importance of recombinant proteins in modern biomedical research.
